Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China flag China · Delayed Price · Currency is CNY
7.80
-0.16 (-2.01%)
Oct 22, 2026, 4:00 PM EDT

SHE:301301 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
490.05769.011,400940.56411.52111.35
Depreciation & Amortization
587.5587.5558.47550.11547.73524.05
Other Amortization
0.880.880.880.991.320.66
Loss (Gain) From Sale of Assets
-0.35-0.35--1.34--0.26
Asset Writedown & Restructuring Costs
30.631.391.251.2831.5516.82
Loss (Gain) From Sale of Investments
3.553.55-0.364.573.7-3.89
Provision & Write-off of Bad Debts
-2.423.69-6.696.5--
Other Operating Activities
571.9663.8672.44127.13138.23167.77
Change in Accounts Receivable
-527.48-527.48-557.51-274.69-424.1978.13
Change in Inventory
-182.29-182.29317.3-335.4653.31-7.75
Change in Accounts Payable
-162.49-162.49-7.99264.92-63.77-80.07
Change in Other Net Operating Assets
-7.3-7.312.4917.9-3.46-0.66
Operating Cash Flow
801.33549.061,7911,292691.64803.21
Operating Cash Flow Growth
-46.10%-69.34%38.59%86.86%-13.89%23.61%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-87.55-97.21-42.6-345.13-47.2-52.27
Sale of Property, Plant & Equipment
0.0500.050.02-0.77
Investment in Securities
-151.56-134.72-64.29--73.34
Other Investing Activities
-1.42-0.63-8.27--
Investing Cash Flow
-240.46-231.93-106.22-353.37-54.2-48.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-747.99780851.81,164932.93
Long-Term Debt Repaid
--818.94-1,622-2,369-1,582-1,514
Lease Payments
-1.6-1.6-60.86-11.94-2.43-0.43
Net Debt Issued (Repaid)
-141.8-70.95-842.19-1,517-417.97-581.5
Issuance of Common Stock
8.7912.9420.26-1,050-
Common Dividends Paid
-403.08-622.1-545.07-290.12-142.82-167.8
Other Financing Activities
-34.886.25.93-1.07-13.42-
Financing Cash Flow
-570.97-673.92-1,361-1,808475.92-749.29

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-5.272.676.543.334.1-6.51
Net Cash Flow
-15.37-354.12330.32-866.111,117-0.76

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
713.78451.851,748947.26644.44750.94
Free Cash Flow Growth
-51.08%-74.16%84.58%46.99%-14.18%33.96%
Free Cash Flow Margin
17.57%9.79%30.36%19.64%16.87%23.23%
Free Cash Flow Per Share
0.320.200.790.420.330.41
Levered Free Cash Flow
790.18367.981,681855.08538.48712.11
Unlevered Free Cash Flow
792.06389.111,719909.94627.44822.66
Free Cash Flow After Leases
712.18450.241,688935.32642750.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
292.03517.11648.47529.02283.66134.55
Change in Working Capital
-880.47-880.47-235.25-337.42-442.41-13.29